3 US Stocks That May Be Trading Below Estimated Value In November 2024

As the United States stock markets reach record highs following Donald Trump's recent election victory, investors are closely examining potential opportunities amidst the surge. In this buoyant environment, identifying stocks that may be trading below their estimated value can offer a strategic advantage for those looking to capitalize on market dynamics.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
NBT Bancorp (NasdaqGS:NBTB)	$50.79	$99.93	49.2%
UMB Financial (NasdaqGS:UMBF)	$125.68	$243.52	48.4%
Synovus Financial (NYSE:SNV)	$58.47	$114.84	49.1%
West Bancorporation (NasdaqGS:WTBA)	$24.35	$46.56	47.7%
Alnylam Pharmaceuticals (NasdaqGS:ALNY)	$273.01	$545.05	49.9%
STAAR Surgical (NasdaqGM:STAA)	$30.86	$59.97	48.5%
Snap (NYSE:SNAP)	$11.81	$22.86	48.3%
AeroVironment (NasdaqGS:AVAV)	$216.32	$416.09	48%
Carter Bankshares (NasdaqGS:CARE)	$20.00	$38.28	47.8%
Rapid7 (NasdaqGM:RPD)	$41.60	$80.91	48.6%

Click here to see the full list of 196 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

HealthEquity (NasdaqGS:HQY)

Overview: HealthEquity, Inc. operates as a technology-enabled services platform offering solutions to consumers and employers in the United States, with a market cap of approximately $7.79 billion.

Operations: HealthEquity generates revenue from its Pharmacy Services segment, which amounted to $1.10 billion.

Estimated Discount To Fair Value: 44.1%

HealthEquity is trading significantly below its estimated fair value, with a share price of US$97.95 against a fair value estimate of US$175.13. Despite recent insider selling, the company reported strong earnings growth, with net income rising to US$35.82 million in Q2 2024 from US$10.58 million the previous year. Revenue is forecast to grow faster than the market at 11.4% annually, supported by innovative initiatives like HSAnswers and strategic financial maneuvers such as a new credit facility and share repurchase program.

• Our earnings growth report unveils the potential for significant increases in HealthEquity's future results.
• Take a closer look at HealthEquity's balance sheet health here in our report.

Moog (NYSE:MOG.A)

Overview: Moog Inc. designs, manufactures, and integrates precision motion and fluid controls systems for aerospace, defense, and industrial markets globally, with a market cap of approximately $6.39 billion.

Operations: The company's revenue segments include Industrial at $991.15 million, Military Aircraft at $811.57 million, Space and Defense at $1.02 billion, and Commercial Aircraft at $788.30 million.

Estimated Discount To Fair Value: 38%

Moog is trading well below its estimated fair value of US$365.41, with a current price of US$226.58, highlighting potential undervaluation based on cash flows. Despite high debt levels, Moog's earnings are projected to grow significantly at 20.2% annually over the next three years, outpacing the broader U.S. market's growth rate. Recent results show an increase in annual net income to US$207.22 million and a new product line launch could support future revenue streams.

• Our growth report here indicates Moog may be poised for an improving outlook.
• Click here and access our complete balance sheet health report to understand the dynamics of Moog.

Synovus Financial (NYSE:SNV)

Overview: Synovus Financial Corp. operates as the bank holding company for Synovus Bank, offering commercial and consumer banking products and services, with a market cap of $7.05 billion.

Operations: Synovus Financial Corp.'s revenue is primarily generated from its Consumer Banking segment at $634.05 million, Community Banking at $467.19 million, Wholesale Banking at $800.47 million, and Financial Management Services (FMS) contributing $281.44 million.

Estimated Discount To Fair Value: 49.1%

Synovus Financial is trading at a significant discount, with its current price of US$58.47 below the estimated fair value of US$114.84, indicating potential undervaluation based on cash flows. The company recently completed a $500 million fixed-income offering to strengthen its financial position. Despite lower profit margins compared to last year, earnings are expected to grow by 33% annually over the next three years, outpacing the U.S. market's growth rate.

• Insights from our recent growth report point to a promising forecast for Synovus Financial's business outlook.
• Click here to discover the nuances of Synovus Financial with our detailed financial health report.

Seize The Opportunity

• Investigate our full lineup of 196 Undervalued US Stocks Based On Cash Flows right here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com